Skip to content

The Effectiveness of Bottle-PEP in Chronic Obstructive Pulmonary Disease

The Effectiveness of Bottle-PEP in Chronic Obstructive Pulmonary Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03900195
Enrollment
50
Registered
2019-04-02
Start date
2019-01-21
Completion date
2020-01-31
Last updated
2019-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The effectiveness of Bottle PEP in patients with Chronic Obstructive Pulmonary Disease

Interventions

OTHERBottlePEP

Positive expiratory device with a bottle

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with COPD * Stable Disease

Exclusion criteria

* Neuromuscular disease * Recent pneumothorax * Major surgery in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Forced expiratory volume in the first minute6 months after interventionPulmonary function tests that are done with a spirometry to measure forced expiratory volume

Secondary

MeasureTime frameDescription
6 minute walking test6 months after intervention6 minute walking test is a field test that measures the distance a patient walks during a 6 minute period.
St. George's Quality of Life Score6 months after interventionScores are calculated for three domains: Symptoms, Activity and Impacts (Psycho-social) as well as a total score. Psychometric testing has demonstrated its repeatability, reliability and validity. Sensitivity has been demonstrated in clinical trials. A minimum change in score of 4 units was established as clinically relevant after patient and clinician testing. This score has been used in a range of disease groups including asthma, chronic obstructive pulmonary disease and bronchiectasis, and in a range of settings such as randomised controlled therapy trials and population surveys.

Countries

Turkey (Türkiye)

Contacts

Primary ContactOzge Kenis Coskun, Asisstant Prof.
ozgekenis@gmail.com+905058294947

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026